Clearmind Medicine Inc.
Market Cap
$102.49K
P/E Ratio
-0.03
EPS
$-24.12
Dividend Yield
0.00%
52-Week Range
$0.70 — $52.40
Volume
629.88K
Avg Volume
233.74K
Beta
-1.05
P/E (TTM)
-0.03
Forward P/E
—
PEG Ratio
-0.01
P/S (TTM)
0.00
P/B (TTM)
0.11
P/FCF
—
EV/EBITDA
—
EV/Sales
—
ROE (TTM)
-2.08%
ROA (TTM)
-0.60%
ROIC
—
Gross Margin
0.00%
Operating Margin
0.00%
Net Margin
—
Debt/Equity
0.00
Current Ratio
3.79
EPS Growth (YoY)
—
Revenue Growth (YoY)
—
EPS Growth (3Y)
+0.75%
EPS Growth (5Y)
-1.40%
Sales Growth (3Y)
+0.00%
Sales Growth (5Y)
+0.00%
EPS Est (This Year)
—
EPS Est (Next Year)
—
Dividend Yield
—
Annual Dividend
—
Payout Ratio
—
Frequency
—
Ex-Dividend Date
—
Cash/Share
$12.15
Institutional %
—
Inst. Net Change
—
Insider Net Shares (90d)
—
Outstanding Shares
136.66K
Float
101.57K
Free Float %
74.33%
Sector
Healthcare
Industry
Biotechnology
Country
CA
Exchange
NASDAQ
IPO Date
2022-11-15
Employees
4
CEO
Adi Zuloff-Shani
Index Membership
—
Website
https://www.clearmindmedicine.com
Clearmind Medicine Inc. (CMND) is a healthcare company in the biotechnology industry listed on the NASDAQ. With a market capitalization of $102.49K, a P/E ratio of -0.03, CMND is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare CMND against other stocks using dozens of fundamental and technical filters.
AGMB
AgomAb Therapeutics N.V. American Depositary Shares
$13.71
-4.23%
$342.75K
WINT
Windtree Therapeutics, Inc.
$0.01
+50.00%
$505.63K
ELAB
PMGC Holdings Inc.
$4.44
-8.26%
$78.48K
ONCO
Onconetix, Inc.
$0.52
+1.55%
$298.92K
BCTXZ
BriaCell Therapeutics Corp. Warrant
$0.11
+0.00%
$209.47K
COEPW
Coeptis Therapeutics Holdings, Inc.
$0.01
-1.00%
$57.05K
Clearmind Medicine Inc. (CMND) has a trailing twelve-month (TTM) P/E ratio of -0.03. This is below the market average, which may suggest the stock is undervalued or has lower growth expectations. The P/E ratio measures how much investors are willing to pay per dollar of earnings.
No, Clearmind Medicine Inc. (CMND) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.
Clearmind Medicine Inc. (CMND) has a market capitalization of $102,494, classifying it as a micro-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.